- Home
- MASS vs ADAG Comparison
MASS vs ADAG Comparison
Compare MASS & ADAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MASS
- ADAG
- Stock Information
- Founded
- MASS 2012
- ADAG 2011
- Country
- MASS United States
- ADAG China
- Employees
- MASS N/A
- ADAG N/A
- Industry
- MASS Medical/Dental Instruments
- ADAG Biotechnology: Pharmaceutical Preparations
- Sector
- MASS Health Care
- ADAG Health Care
- Exchange
- MASS Nasdaq
- ADAG Nasdaq
- Market Cap
- MASS 84.3M
- ADAG 81.9M
- IPO Year
- MASS 2020
- ADAG 2021
- Fundamental
- Price
- MASS $5.79
- ADAG $1.60
- Analyst Decision
- MASS Buy
- ADAG Strong Buy
- Analyst Count
- MASS 3
- ADAG 1
- Target Price
- MASS $5.33
- ADAG $8.00
- AVG Volume (30 Days)
- MASS 456.1K
- ADAG 15.4K
- Earning Date
- MASS 05-13-2025
- ADAG 03-24-2025
- Dividend Yield
- MASS N/A
- ADAG N/A
- EPS Growth
- MASS N/A
- ADAG N/A
- EPS
- MASS N/A
- ADAG N/A
- Revenue
- MASS $59,631,000.00
- ADAG $103,204.00
- Revenue This Year
- MASS N/A
- ADAG $6,488.89
- Revenue Next Year
- MASS $18.84
- ADAG $57.50
- P/E Ratio
- MASS N/A
- ADAG N/A
- Revenue Growth
- MASS 18.72
- ADAG N/A
- 52 Week Low
- MASS $1.81
- ADAG $1.33
- 52 Week High
- MASS $7.48
- ADAG $3.58
- Technical
- Relative Strength Index (RSI)
- MASS 66.62
- ADAG 51.88
- Support Level
- MASS $5.01
- ADAG $1.51
- Resistance Level
- MASS $5.73
- ADAG $1.74
- Average True Range (ATR)
- MASS 0.41
- ADAG 0.10
- MACD
- MASS -0.00
- ADAG 0.03
- Stochastic Oscillator
- MASS 89.58
- ADAG 61.84
About MASS 908 Devices Inc.
908 Devices Inc manufactures medical devices. It has developed a suite of purpose-built handheld and desktop mass spectrometry, or Mass Spec, devices for the point-of-need. Mass Spec devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the critical problems in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company geographically derives maximum revenue from United States, and also has its presence in Europe, Middle East and Africa, Americas and Other and Asia Pacific.
About ADAG Adagene Inc.
Adagene Inc platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity as highlighted by the company's immunotherapy pipeline.